Beijing Anding Hospital of Capital Medical University

Beijing 100088

0 studies enrolling now · 3 studies all time

What they study most

Anhedonia, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

Studies at this site

• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
• A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression — Completed